Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorSecond Affiliated Hospital of Xi'an Jiaotong University

About this trial

The objective of this research is to investigate the clinical outcomes of modified surgical techniques such as omitting the cervical linea alba suture in transthoracic endoscopic thyroidectomy. Furthermore, the study requires the collection of normal thyroid tissues, benign and malignant thyroid tumors, and lymph nodes to further clarify the mechanisms associated with the initiation, progression, metastasis, and recurrence of thyroid cancer.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Perform transthoracic endoscopic thyroidectomy via breast approach;

Postoperative pathology confirms benign or malignant thyroid tumors;

Preoperative thyroid ultrasound or cervical CT suggests no extrathyroidal invasion or distant metastasis of the tumor;

No contraindications for general anesthesia;

Disqualifiers

Underwent transthoracic endoscopic thyroidectomy;

Postoperative pathology confirmed as benign or malignant thyroid tumors;

Preoperative thyroid ultrasound or neck CT suggested no extraglandular invasion or distant metastasis of the tumor;

No contraindications to general anesthesia;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Suturing the cervical linea alba during endoscopic thyroid surgery.

    Procedure/Surgery

    Suturing the cervical linea alba during endoscopic thyroid surgery.

  • Performing transcriptome sequencing

    Genetic

    Performing transcriptome sequencing

Treatment groups

170 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Group A: Suturing the cervical linea alba during endoscopic thyroid surgeryExperimental treatment 1 intervention
Group B: Not suturing the cervical linea alba during endoscopic thyroid surgeryNo intervention 0 interventions
Group C: Thyroid papillary carcinoma groupOther 1 intervention
Group D: Thyroid papillary carcinoma adjacent groupOther 1 intervention
Group E: Lymph node metastasis groupOther 1 intervention
Group F: Non-lymph node metastasis groupOther 1 intervention

Trial outcomes

Primary outcomes

1

Postoperative neck edema Incidence rate

Postoperative neck edema Incidence rate

Time frame
Within one week post-surgery
2

Postoperative short-term pain

Record the patient's perception of wound pain on postoperative days 1, 3, and 5 using the Numerical Rating Scale (NRS), which ranges from 0 (no pain) to 10 (worst pain), for quantification.

Time frame
Within one week post-surgery
3

Thyroid Papillary carcinoma tissue mRNA expression profile

After extracting total RNA from tissue, it is purified and a cDNA library is constructed. Following library quality control, sequencing is conducted on the Illumina NovaSeq 6000 platform using the PE150 mode to obtain tissue mRNA expression data.

Time frame
Within one month after the transcriptome sequencing.
4

Thyroid papillary carcinoma metastatic lymph node mRNA expression profile

After extracting total RNA from tissue, it is purified and a cDNA library is constructed. Following library quality control, sequencing is conducted on the Illumina NovaSeq 6000 platform using the PE150 mode to obtain tissue mRNA expression data.

Time frame
Within one month after the transcriptome sequencing.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.